Cargando…

Immune Response and Molecular Mechanisms of Cardiovascular Adverse Effects of Spike Proteins from SARS-CoV-2 and mRNA Vaccines

The SARS-CoV-2 (severe acute respiratory syndrome coronavirus responsible for the COVID-19 disease) uses the Spike proteins of its envelope for infecting target cells expressing on the membrane the angiotensin converting enzyme 2 (ACE2) enzyme that acts as a receptor. To control the pandemic, geneti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bellavite, Paolo, Ferraresi, Alessandra, Isidoro, Ciro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953067/ https://www.ncbi.nlm.nih.gov/pubmed/36830987 http://dx.doi.org/10.3390/biomedicines11020451

Ejemplares similares

Targeting autophagy with natural products to prevent SARS-CoV-2 infection
por: Vidoni, Chiara, et al.
Publicado: (2021)

Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis
por: Trougakos, Ioannis P., et al.
Publicado: (2022)

Will Omics Biotechnologies Save Us from Future Pandemics? Lessons from COVID-19 for Vaccinomics and Adversomics
por: Ferraresi, Alessandra, et al.
Publicado: (2022)

Spike-specific T cells are enriched in breastmilk following SARS-CoV-2 mRNA vaccination
por: Armistead, Blair, et al.
Publicado: (2022)

Spike-specific T cells are enriched in breastmilk following SARS-CoV-2 mRNA vaccination
por: Armistead, Blair, et al.
Publicado: (2023)

Systems Biology in Cancer Diagnosis Integrating Omics Technologies and Artificial Intelligence to Support Physician Decision Making
por: Fawaz, Alaa, et al.
Publicado: (2023)

Causality assessment of adverse events following immunization: the problem of multifactorial pathology
por: Bellavite, Paolo
Publicado: (2020)

Glycosite-deleted mRNA of SARS-CoV-2 spike protein as a broad-spectrum vaccine
por: Wu, Chung-Yi, et al.
Publicado: (2022)

Amino acid response by Halofuginone in Cancer cells triggers autophagy through proteasome degradation of mTOR
por: Follo, Carlo, et al.
Publicado: (2019)

Humoral immune response to SARS-CoV-2 mRNA vaccines is associated with choice of vaccine and systemic adverse reactions
por: Klingel, Hanna, et al.
Publicado: (2023)

Adverse events following measles-mumps-rubella-varicella vaccine: an independent perspective on Italian pharmacovigilance data
por: Bellavite, Paolo, et al.
Publicado: (2021)

Biological and Immune Responses to Current Anti-SARS-CoV-2 mRNA Vaccines beyond Anti-Spike Antibody Production
por: Federico, Maurizio
Publicado: (2022)

Absence of SARS-CoV-2 Spike glycoprotein expression in placentas from individuals after mRNA SARS-CoV-2 vaccination
por: Santos, Andres, et al.
Publicado: (2022)

Anti-spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic Malignancies
por: Greenberger, Lee M., et al.
Publicado: (2022)

ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines
por: Hoffmann, Magnus A.G., et al.
Publicado: (2023)

Current Evidence in SARS-CoV-2 mRNA Vaccines and Post-Vaccination Adverse Reports: Knowns and Unknowns
por: Mouliou, Dimitra S., et al.
Publicado: (2022)

SARS-CoV-2 mRNA vaccination and subsequent herpes zoster: Possible immune reconstitution by mRNA vaccination
por: Ota, Mitsuhito
Publicado: (2022)

Humoral immune responses against SARS-CoV-2 Spike variants after mRNA vaccination in solid organ transplant recipients
por: Tauzin, Alexandra, et al.
Publicado: (2022)

Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine
por: Tauzin, Alexandra, et al.
Publicado: (2023)

Hesperidin and SARS-CoV-2: New Light on the Healthy Function of Citrus Fruits
por: Bellavite, Paolo, et al.
Publicado: (2020)

SARS‐CoV‐2 spike mRNA vaccine sequences circulate in blood up to 28 days after COVID‐19 vaccination
por: Castruita, Jose Alfredo Samaniego, et al.
Publicado: (2023)

Passive inhaled mRNA vaccination for SARS-Cov-2
por: Yeo, Wee Song, et al.
Publicado: (2021)

Approved mRNA Vaccines for SARS-CoV-2
por: Faiman, Beth
Publicado: (2021)

Is SARS-CoV-2 prior infection related with more adverse effects to mRNA vaccine in healthcare workers?
por: Garcia, Cristina Meno, et al.
Publicado: (2022)

Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents
por: Bardenheier, Barbara H., et al.
Publicado: (2021)

The Screening of Broadly Neutralizing Antibodies Targeting the SARS-CoV-2 Spike Protein by mRNA Immunization in Mice
por: An, Zhiyin, et al.
Publicado: (2023)

COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
por: Giannotta, Girolamo, et al.
Publicado: (2023)

The metabolic cross‐talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: Autophagy plays a role
por: Thuwajit, Chanitra, et al.
Publicado: (2017)

Secretory IgA and T cells targeting SARS-CoV-2 spike protein are transferred to the breastmilk upon mRNA vaccination
por: Gonçalves, Juliana, et al.
Publicado: (2021)

Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female mice
por: Prompetchara, Eakachai, et al.
Publicado: (2023)

Quantification of SARS-CoV-2 spike protein expression from mRNA vaccines using isotope dilution mass spectrometry
por: Sutton, William J.H., et al.
Publicado: (2023)

Kinetics of the Neutralizing and Spike SARS-CoV-2 Antibodies following the Sinovac Inactivated Virus Vaccine Compared to the Pfizer mRNA Vaccine in Singapore
por: Lau, Chin Shern, et al.
Publicado: (2022)

Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine
por: Agrati, Chiara, et al.
Publicado: (2022)

Hypereosinophilia after vaccination with the SARS-CoV-2 mRNA vaccines
por: Westreich, Aaron, et al.
Publicado: (2023)

Nuclear translocation of spike mRNA and protein is a novel feature of SARS-CoV-2
por: Sattar, Sarah, et al.
Publicado: (2023)

Association of Systemic Adverse Reactions and Serum SARS-CoV-2 Spike Protein Antibody Levels after Administration of BNT162b2 mRNA COVID-19 Vaccine
por: Takahashi, Wataru, et al.
Publicado: (2022)

Ramsay Hunt syndrome and mRNA SARS-COV-2 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Ramsay Hunt syndrome and mRNA SARS-COV-2 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

B-Cell Responses to Sars-Cov-2 mRNA Vaccines
por: Kardava, Lela, et al.
Publicado: (2022)

Collagenous colitis following SARS‐Cov2 mRNA vaccination
por: Iketani, Momoko, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v2giv02s50m1svkiuplf5junej